Cita APA

Cui, Y., Tong, H., Du, X., Li, B., Gale, R. P., Qin, T., . . . Xiao, Z. (2016). TET2 mutations were predictive of inferior prognosis in the presence of ASXL1 mutations in patients with chronic myelomonocytic leukemia. Stem Cell Investig.

Citación estilo Chicago

Cui, Yajuan, et al. "TET2 Mutations Were Predictive of Inferior Prognosis in the Presence of ASXL1 Mutations in Patients With Chronic Myelomonocytic Leukemia." Stem Cell Investig 2016.

Cita MLA

Cui, Yajuan, et al. "TET2 Mutations Were Predictive of Inferior Prognosis in the Presence of ASXL1 Mutations in Patients With Chronic Myelomonocytic Leukemia." Stem Cell Investig 2016.